Start Vaccinating News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India to start vaccinating 12 to 14-year-olds against COVID-19

So these are some early clues and they -- they have to see how this continues to -- if that data continues to hold up. one thing i think is interesting, anderson, if you look at the trajectory in south africa over the past few variants and sort of look what has happened. the original variant, and then beta, delta, you see sort of this interesting -- you know, these interesting peaks. i don't know if we have the graphic, we can put it up. but basically, you see a significant surge and then a period of quieting. and then, another significant surge. keep in mind, they didn't start vaccinating unt...

This continues to -- if that data continues to hold up. one thing i think is interesting, anderson, if you look at the trajectory in south africa over the past few variants and sort of look what has happened. the original variant, and then beta, delta, you see sort of this interesting -- you know, these interesting peaks. i don't know if we have the graphic, we can put it up. but basically, you see a significant surge and then a period of quieting. and then, another significant surge. keep in mind, they didn't start vaccinating until february of this year and they still have pretty low vaccina...

Singapore to Start Vaccinating 12-18 Year-old Adolescents as PM Outlines Reopening Plans News18 2 hours ago © Provided by News18 Singapore to Start Vaccinating 12-18 Year-old Adolescents as PM Outlines Reopening Plans Singapore is opening up its Covid-19 vaccination programme to adolescents from Tuesday to help contain the latest outbreak that has infected some students, and will step up testing and tracing. The city-state is among the first countries in the world to offer vaccines to teenagers before completing inoculation of adults. The city-state will open up vaccination for 12-18 yea...

The U.S. expects to have enough coronavirus vaccine to meet U.S. demand by May despite a planned pause in the use of Johnson & Johnson’s shot pending a review of rare blood clots. J&J said it’s delaying its rollout in Europe.